Carnitine therapy is associated with decreased hospital utilization among hemodialysis patients.

  title={Carnitine therapy is associated with decreased hospital utilization among hemodialysis patients.},
  author={Waqar Husain Kazmi and Gregorio T. Obrador and Maya Sternberg and Jill Lindberg and Brian Schreiber and Vyoone Lewis and Brian J. G. Pereira},
  journal={American journal of nephrology},
  volume={25 2},
BACKGROUND/AIMS Hospitalizations account for 41% of the total cost of end-stage renal disease (ESRD) care. Carnitine deficiency is common among dialysis patients, and some studies have shown improvements in anemia, and cardiac and skeletal muscle function upon administration of L-carnitine. We hypothesized that L-carnitine may be associated with decreased hospital utilization in these patients. METHODS The Fresenius Medical Care North America dialysis database was used for this retrospective… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 10 extracted citations

L-carnitine level in hemodialysis patients

Dejanova Beti, Dejanov Petar, Petrovska Suncica, Sikole Aleksandar
View 1 Excerpt

Effect of L-carnitine administration on erythropoietin use in thalassemic minor haemodialysis patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2007

Similar Papers

Loading similar papers…